L.E.A.F. Pharmaceuticals Lead Investigational Product for Lung...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
VALLEY FORGE, Pennsylvania, June 10, 2020 /PRNewswire-AsiaNet/ -- -- Treatment with LEAF-1401 exposes the tumor to 20-times more pentaglutamated pemetrexed than conventional pemetrexed.Polyglutamated pemetrexed has been shown to be 80-times more potent than pemetrexed in inhibiting thymidylate synthase (TS), a...
Authors: LATEST ASIANET NEWS RELEASES